Aeolus Pharmaceuticals is focused on the development of a new class of catalytic antioxidant compounds that protects healthy tissue from the damaging effects of radiation. Aeolus’ first compound is AEOL 10150, which is being developed for oncology indications to be used in combination with radiation therapy. With funding by the U.S. Government, AEOL 10150 is also being developed as a medical countermeasure against chemical and radiological weapons. For more information visit the company’s Web site at www.aeoluspharma.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: